Intent to Sole Source - Untargeted Metabolomics Analysis
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Metabolon, Inc. Acquisition Description: The TBHP Branch (TBHP) requests the purchase of a contract for Metabolon, Inc., to perform untargeted metabolomics analysis of human fecal samples. The materials will be used in a collaborative protocol between the NIH Clinical Center TBHP Branch, the National Institute of Diabetes and Digestive and Kidney Diseases, and the National Heart, Lung, and Blood Institute to quantify and compare microbiome-derived metabolites and dietary xenobiotics in diets primarily consisting of unprocessed and ultra-processed food to investigate metabolic pathways altered by ultra-processed diets. The metabolomics analysis needs to be able to: Detect and quantify a broad panel of small-molecule metabolites (including dietary xenobiotics and microbiota-derived compounds) in fecal samples Enable simultaneous analysis of a large array of cytokines, chemokines, and metabolites in small sample volumes Interface with Thermo Fisher Scientific Luminex platforms for downstream immune/metabolic biomarker analysis Provide comprehensive untargeted metabolite coverage validated for use with human fecal samples. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-008751) by 12:00 PM eastern standard time on 08/31/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Key dates
Response due
August 31, 2026
- Posted
- August 21, 2026
Details
- Agency
- National Institutes of Health
- Buyer type
- Federal
- Jurisdiction
- the United States (US)
- Category
- Clinical
- Value
- —
- Set-aside
- No Set aside used
- NAICS
- 541380
- PSC
- Q301
- Source
- sam.gov
Who is this buyer
Organization
Source: Provider universeNot matched to a provider record yet.
Buying history
Source: Solicitation records- Records17 total
- Opportunities / awards9 / 0
- ActiveJuly 21, 2026 – August 21, 2026
What they buy
- Clinical (15)
- Administrative (2)
Set-asides used
- No Set aside used (16)
Financial highlights
Source: IRS Form 990No 990 filing on record.
Who holds their work today
Source: Solicitation records · awardsNo awards on record for this buyer.
What they're trying to solve
Source: AI-generatedNo brief written for this buyer yet.
Also open from this buyer
Source: Solicitation records- Intent to Sole Source - ClinicalPACS VUE SpeechMike integration with PowerScribeDue September 4, 2026 · Clinical
- Intent to Sole Source - Fluorescent Cell Culture MicroscopeDue August 31, 2026 · Clinical
- Intent to Sole Source - Water Filter SystemDue August 30, 2026 · Clinical
- Transcriptomic characterization of plasma exosomesDue August 31, 2026 · Clinical
Ways to meet this buyer
Source: Solicitation records · event noticesUpcoming
No upcoming events on record.
View source document →
Source link on sam.gov.